Group Finds Discrepancies In Implementation Of Nagoya Protocol Between EU, Providers 15/12/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment A new report by two civil society groups explores what they say are discrepancies between European Union and provider country laws implementing the Nagoya Protocol on genetic resources, which they say could lead to legal uncertainties for users and providers.
Idea Of A Multilateral Investment Court Makes Headway, Proponents Say 15/12/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The European Union and Canada held an informal meeting in Geneva this week to present a project for a multilateral investment court to handle global investor-state disputes, hoping to draw interest and questions by other country delegates, according to sources. Time will be needed to gain acceptance of the idea, they said, and the next opportunity will be at the January World Economic Forum in Davos.
EU, Canada Meet To Discuss A New Model For Investor-State Trade Disputes 13/12/2016 by Monika Ermert for Intellectual Property Watch Leave a Comment The European Commission and the Canadian government today and tomorrow are hosting a first meeting for talks on a new multilateral investment court. Such a court could, the European Commission explained in an announcement, become the follow-up mechanism for the existing investor-state dispute settlement (ISDS) provisions that are part of 3,200 bilateral and multilateral free trade agreements around the world.
UAEM Targets Accessible Medicines, R&D Financing, Publicly Funded Research 13/12/2016 by Alexandra Nightingale for Intellectual Property Watch 1 Comment From extracurricular creativity to global campaigns, Universities Allied for Essential Medicines (UAEM) continues in its activities to raise awareness and explore how universities can best direct their research and innovations towards promoting global access to medicines. In the next year, UAEM will extend its national and international campaigns to address the high prices of medicines, continue to gather support for a global agreement on research and development and build on the mapping alternative R&D initiatives.
Els Torreele Named Executive Director Of Global MSF Access Campaign 08/12/2016 by William New, Intellectual Property Watch 2 Comments Veteran public health advocate Els Torreele of Belgium has been named the new executive director of the high-profile Médecins Sans Frontières (MSF, Doctors Without Borders) Access Campaign, based in Geneva.
Proposed EU Neighbouring Rights For Press Publishers Detrimental To Authors, CEIPI Says 07/12/2016 by Intellectual Property Watch Leave a Comment According to the Centre for International Intellectual Property Studies, the proposed European Commission copyright reform is detrimental to authors’ interests, and contrary to the objective of creating a single digital market.
Russia To Establish New IP Register For Military Equipment, Weapons 06/12/2016 by Eugene Gerden for Intellectual Property Watch 2 Comments A new register of intellectual property in the field of military and defence will soon be established in Russia in accordance with a recent decision of the national government, according to the state press service.
Thomas Cueni Of Switzerland Named Director General Of IFPMA 02/12/2016 by William New, Intellectual Property Watch Leave a Comment Thomas Cueni of Switzerland has been named the next director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the Geneva-based organisation which represents the global research-based pharma industry.
ILO Decisions Said To Confirm EPO Staff Lack Fair Legal System 01/12/2016 by Dugie Standeford for Intellectual Property Watch 2 Comments The International Labour Organization Administration Tribunal (ILO-AT) on 30 November set aside two European Patent Office (EPO) decisions rejecting employee challenges to various internal rules. The judgments, which sent the complaints back to the EPO on the grounds that they had not been handled by the proper authorities, highlight the lack of a “fair and functioning” legal system for EPO staff, said an employee source who asked to remain anonymous.
Pfizer CEO Ian Read Elected To Rotating IFPMA Presidency 30/11/2016 by Intellectual Property Watch Leave a Comment Pfizer Board Chairman and CEO Ian Read has been elected as the next president of the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), a two-year role.